Gourt > Health > Pharmacy > Drugs and Medications > F > Frovatriptan
Frovatriptan (Frova®) is a triptan drug developed by Endo Pharmaceuticals for the treatment of migraine headaches. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2.5 mg tablets.
Frovatriptan has mean terminal elimination half-life of approximately 26 hours, which is substantially longer than for other triptans.
Frovatriptan is available only by prescription in the United States.
More on [ Frovatriptan ]
Frova Consumer Information - FDA - Patient FAQ in html format with a link to approved labeling in pdf format.
Meta Description: [ Consumer Information Sheet ]
Frovatriptan - FamilyDoctor.org - Information for patients in English or Spanish.
